AVITA Medical Inc (RCEL)
13.34
+0.47
(+3.65%)
USD |
NASDAQ |
Nov 22, 16:00
13.32
-0.02
(-0.15%)
After-Hours: 20:00
AVITA Medical Debt to Equity Ratio: 3.480 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.480 |
| June 30, 2024 | 1.714 |
| March 31, 2024 | 1.268 |
| December 31, 2023 | 0.8116 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
3.480
Maximum
Sep 2024
0.4041
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 0.0157 |
| InfuSystems Holdings Inc | 0.5039 |
| Xtant Medical Holdings Inc | 0.7605 |
| Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.05M |
| Total Liabilities (Quarterly) | 68.82M |
| Shareholders Equity (Quarterly) | 12.23M |
| Current Ratio | 3.729 |
| Net Debt Paydown Yield | -3.03% |